Bacterial translocation in multiple organ failure: Cause or epiphenomenon still unproven

British Journal of Surgery

Volumn 84, Issue 10, 1997, Pages 1340-1350

  Lemaire, L C J M ^a   Van Lanschot, J J B ^a   Stoutenbeek, C P ^a   Van Deventer, S J H ^b   Wellsf, C L ^a   Gouma, D J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

BACTERIAL TRANSLOCATION; HUMAN; INFLAMMATION; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BACTERIAL TRANSLOCATION; HUMANS; MULTIPLE ORGAN FAILURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0030760282     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800841005     Document Type: Review

References (152)

1. Goris RJA, te Brockhorst TPA, Nuytinck JKS, Gimbrcre JSF. Multiple organ failure. Generalized autodestructive inflammation?Arch Siirg 1985; 120: 1109-15.
2. Tran DD, Cuesta MA, Van Lccuwen PAM, Nauta JJP, Wesdorp RIC. Risk factors for multiple organ system failure and death in critically injured patients. Surgery 1993; 114: 21-30.
3. Henao FJ, Daes JE, Dennis RJ. Risk factors for multiorgan failure: a case-control study. J Trauma 1991; 31: 74-80.
4. Fry DE, Pearlstein L, Fulton RL, Polk HC Jr. Multiple system organ failure. The role of uncontrolled infection. Arch Siirg 1980; 115: 136-40.
5. Knaus NVA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Siirg 1985; 202: 685-93.
6. Barriere SL, Lowry SF. An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23: 376-93.
7. Eiscman B, Beart R, Norton L. Multiple organ failure. Siirg Gynccol Obstet 1977; 144: 323-6.
8. Faist E, Baue AE, Dittmer H, Heberer G. Multiple organ failure in polytrauma patients. J Trauma 1983; 23: 775-87.
9. Roumen RMH, Hendriks T, van der Vcn-Jongekrijg J et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with, subsequent adult respiratory distress syndrome and multiple organ failure. Ann Siirg 1993; 218: 769-76.
10. Waydhas C, Nast-Kolb D, Jochum M et al. Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Siirg 1992; 127: 460-7.
11. Michie HR, Spriggs DR, Manogue KR et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 1988; 104: 280-6.
12. Hawes AS, Fischer E, Marano MA et al. Comparison of peripheral blood leukocyte kinetics after live Escherichia coli, endotoxin or interleukin-la administration. Studies using a novel interleukin-1 receptor antagonist. Ann Siirg 1993; 218: 79-90.
13. van der Poll T, van Deventer SJH, Hack CE et al. Effects of leukocytes after injection of tumour necrosis factor into healthy humans. Blood 1992; 79: 693-8.
14. Roumen RMH, Redl H, Schlag G et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995;23:474-80.
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
16. Béai AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994; 271: 226-33.
17. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Siirg Clin North Am 1995; 75: 257-77.
18. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996; 24: 163-72.
19. Bone RC. Immunologie dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996; 125: 680-7.
20. Fukushima R, Alexander JW, Gianotti L, Ogle CK. Isolated pulmonary infection acts as a source of systemic tumour necrosis factor. Crit Care Med 1994; 22: 114-20.
21. Volk HD, Thieme M, Heym S et al. Alterations in function and phenotype of monocytes from patients with septic disease: predictive value and new therapeutic strategics. Behring Inst Mitt 1991; 88: 208-15.
22. Goldie AS, Fearon KCH, Ross JA et al. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA 1995; 274: 172-7.
23. '23 Borelli E, Roux-Lombard P, Grau G et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24: 392-7.
24. Randow F, Syrbe U, Meisel C et al. Mechanism of endotoxin desensitization: involvement of intcrleukin 10 and transforming growth factor β. / Exp Med 1995; 181: 1887-92.
25. Herschman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Sitrg 1990; 77: 204-7.
26. Kox WJ, Bone RC, Krausch D et al. Interferon gamma-lb in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch Intern Med 1997; 157: 389-93.
27. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992; 216: 117-34.
28. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269:1829-35.
29. Schlag G, Redl H, Hallstrom S. The cell in shock: the origin of multiple organ failure. Resuscitation 1991; 21: 137-80.
30. Wang X, Andersson R. The role of endothelial cells in the systemic inflammatory response syndrome and multiple system organ failure. EitrJSurg 1995; 161: 703-13.
31. Bulkley GB. Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function. Lancet 1994; 344: 934-6.
32. Van Deventer SJH, Gouma DJ. Bacterial translocation and endotoxin transmigration in intestinal ischaemia and reperfusion. Cuir Opin Anacsth 1994; 7: 126-30.
33. Tokyay R, Zeiglcr ST, Traber DL et al. Postburn gastrointestinal vasoconstriction increases bacterial and endotoxin translocation. JAppl Physiol 1993; 74: 1521-7.
34. Tokyay R, Zeigler ST, Heggers JP, Loick HM, Traber DL, Herndon DN. Effects of anesthesia, surgery, fluid resuscitation, and endotoxin administration on postburn bacterial translocation. J Trauma 1991; 31: 1376-9.
35. Koike K, Moore EE, Moore FA, Read RA, Carl VS, Banerjee A. Gut ischemia-reperfusion produces lung injury independent of endotoxin. Crit Care Med 1994; 22: 1438-44.
36. Hill J, Lindsay TF, Ortiz F, Yeh CG, Hechtman HB, Moore FD Jr. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemiareperfusion in the rat. /1 minimal 1992; 149: 1723-8.
37. Hill J, Lindsay T, Valeri CR, Shepro D, Hechtman HB. A CD18 antibody prevents lung injury but not hypotension after intestinal ischemia-reperfusion. J Appl Physiol 1993; 74: 659-64.
38. Hill J, Lindsay T, Rusche J, Valeri CR, Shepro D, Hechtman HB. A Mac-1 antibody reduces liver and lung injury but not neutrophil sequestration after intestinal ischemia-reperfusion. Surgery 1992; 112: 166-72.
39. Terada LS, Dormish JJ, Shanley PF, Leff JA, Anderson BO, Repine JE. Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. Am J Physiol 1992; 263: L394-401.
40. van Deventer SJH, ten Gate JW, Tytgat GNJ. Intestinal endotoxemia. Clinical significance. Gastrocnterology 1988; 94: 825-31.
41. Müller-Alouf H, Alouf JE, Gerlach D, Ozegowski JH, Fitting C, Cavaillon JM. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogcncs superantigenic erythrogenic toxins, heat-killed streptococci and lipopolysaccharide. Infect Immun 1994; 62: 4915-21.
42. Müller-Alouf H, Alouf JE, Gerlach D, Ozegowski JH, Fitting C, Cavaillon JM. Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens. Infect Immun 1996; 64: 1450-3.
43. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mcsenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979; 23: 403-11.
44. Fraenkel A. Ueber peritoneale infection. Wien Klin Wochensctir 1891; 13: 241-5, 265-8, 285-9.
45. Flexner S. Peritonitis caused by the invasion of the micrococcus Lanccolaius from the intestine. Johns Hopkins Hospital Bulletin 1895; 49: 64-7.
46. Hirsch R. Lieber das Vorkommen von Stärkekörnern im Blut und im Urin. Zeitschrift für Experimentelle Pathologie und Therapie 1906; 3: 390-2.
47. Schweinburg FB, Hcimberg F. Effect of chemical irrigation of the peritoneum on transmural migration of intestinal organisms. Proc Soc Exp Dial Med 1949; 71: 146-50.
48. Schweinburg FB, Frank HA, Frank ED, Heimberg F, Fine J. Transmural migration of intestinal bacteria during peritoneal irrigation in urémie dogs. Proc Soc Exp Biol Med 1949; 71: 150-3.
49. Schweinburg FB, Seligman AM, Fine J. Transmural migration of intestinal bacteria. A study based on the use of radioactive Escliericliia coli. N Engl J Med 1950; 242: 747-51.
50. Schatten WE, Desprez JD, Holden WD. A bactériologie study of portal-vein blood in man. Arch Surg 1955; 71: 404-9.
51. Hildebrand GJ, Wolochow H. Translocation of bacteriophage across the intestinal wall of the rat. Proc Soc Exp Biol Med 1962; 109: 183-5.
52. Ravin HA, Rowley D, Jenkins C, Fine J. On the absorption of bacterial endotoxin from the gastrointestinal tract of the normal and shocked animal. J Exp Med 1960; 112: 783-92.
53. Caridis DT, Reinhold RB, Woodruff PWH, Fine J. Endotoxaemia in man. Lancet 1972; ii: 1381-5.
54. Alexander JW, Boyce ST, Babcock GF et al. The process of microbial translocation. Ann Surg 1990; 212: 496-512.
55. Krause W, Matheis H, Wulf K. Fungaemia and funguria after oral administration of Candida albicans. Lancet 1969; ii: 598-9.
56. Wells CL, Maddaus MA, Simmons RL. Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 1988; 10: 958-79.
57. Steffen EK, Berg RD, Deitch EA. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis 1988; 157: 1032-8.
58. Simon GL, Gelfand JA, Connolly RA, O'Donnell TF Jr, Gorbach SL. Experimental Bacteroidcs fragilis bacteremia in a primate model: evidence that Bacteroides fragilis does not promote the septic shock syndrome. J Trauma 1985; 25: 1156-62.
59. Wells CL, Maddaus MA, Reynolds CM, Jechorek RP, Simmons RL. Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun 1987; 55: 2689-94.
60. Brandtzaeg P, Halstenscn TS, Kelt K et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithclial lymphocytes. Gastroenterology 1989; 97: 1562-84.
61. Kagnoff MF. Immunology of the intestinal tract. Gastroenterology 1993; 105: 1275-80.
62. Wells CL, Maddaus MA, Erlandsen SL, Simmons RL. Evidence for the phagocytic transport of intestinal particles in dogs and rats. Infect Immun 1988; 56: 278-82.
63. Wells CL, Jechorek RP, Erlandsen SL. Evidence for the translocation of Entcrococcus faecalis across the mouse intestinal tract. J Infect Dis 1990; 162: 82-90.
64. Maddaus MA, Wells CL, Platt JL, Condie RM, Simmons RL. Effect of T cell modulation on the translocation of bacteria from the gut and mesenteric lymph node. Ann Surg 1988; 207: 387-98.
65. Gautrcaux MD, Dcitch EA, Berg RD. T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract. Infect Immun 1994; 62: 2874-84.
66. Runkel NSF, Moody FO, Smith GS et al. Alterations in rat k intestinal transit by morphine promote bacterial translocation. Dig Dis Sei 1993; 38: 1530-6.
67. Kueppers PM, Miller TA, Chen CY, Smith GS, Rodriguez LF, Moody FG. Effect of total parenteral nutrition plus morphine on bacterial translocation in rats. Ann Surg 1993; 217: 286-92.
68. Maxson RT, Dunlap JP, Tryka F, Jackson RJ, Smith SD. The role of the mucus gel layer in intestinal bacterial translocation. / Surg Res 1994; 57: 682-6.
69. Barber AE, Jones WG II, Minei JP, Fahcy TJ III, Lowry SF, Shires GT. Bacterial overgrowth and intestinal atrophy in the etiology of gut barrier failure in the rat. Am J Surg 1991; 161: 300-4.
70. Illig KA, Ryan CK, Hardy DJ, Rhodes J, Locke W, Sax HC. Total parenteral nutrition-induced changes in gut mucosal function: atrophy alone is not the issue. Surgery 1992; 112: 631-7.
71. Haskel Y, Xu D, Lu Q, Deitch EA. Elemental diet-induced bacterial translocation can be hormonally modulated. Ann Surg 1993; 217: 634-43.
72. Speath G, Gottwald T, Specian RD, Mainous MR, Berg RD, Deitch EA. Secretory immunoglobulin A, intestinal mucin, and mucosal permeability in nutritionally induced bacterial translocation in rats. Ann Surg 1994; 220: 798-808.
73. Shou J, Lappin J, Minnard EA, Daly JM. Total parenteral nutrition, bacterial translocation, and host immune function. Am J Surg 1994; 167: 145-50.
74. Deitch EA, Xu D, Naruhn MB, Deitch DC, Lu Q, Marino AA. Elemental diet and iv-TPN-induced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria. Ann Surg 1995; 221: 299-307.
75. Deitch EA, Bridges W, Baker J et al. Hemorrhagic shockinduced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgeiy 1988; 104: 191-8.
76. Baker JW, Deitch EA, Li M, Berg RD, Specian RD. Hemorrhagic shock induces bacterial translocation from the gut. / Trauma 1988; 28: 896-906.
77. Deitch EA, Morrison J, Berg RD, Specian RD. Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit Care Med 1990; 18: 529-36.
78. Yong-Ming Y, Bahrami S, Leichtfried G, Redl H, Schlag G. Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/ permeability-increasing protein. Ann Surg 1995; 221: 398-405.
79. Tokyay R, Zeigler ST, Heggers JP, Loick HM, Traber DL, Herndon DN. Effects of anesthesia, surgery, fluid resuscitation and endotoxin administration on postburn bacterial translocation. J Trauma 1991; 31: 1376-9.
80. Tokyay R, Zeigler ST, Traber DL et al. Postburn gastrointestinal vasoconstriction increases bacterial and endotoxin translocation. JAppl Pliysiol 1993; 74: 1521-7.
81. Fukushima R, Gianotti L, Alexander JW, Pyles T. The degree of bacterial translocation is a determinant factor for mortality after burn injury and is improved by prostaglandin analogs. Ann Surg 1992; 216: 438-45.
82. Zapata-Sirvcnt RL, Hansbrough JF, Ohara MM, Rice-Asaro M, Nyhan VVL. Bacterial translocation in burned mice after administration of various diets including fiber- and glutamine-enriched enterai formulas. Crit Care Med 1994; 22: 690-6.
83. Go LL, Healey PJ, Watkins SC, Simmons RL, Rowe MI. The effect of endotoxin on intestinal mucosal permeability to bacteria m vitro. Arch Surg 1995; 130: 53-8.
84. Zhi-Yong S, Dong Y-L, Wang X-H. Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion. J Trauma 1992; 32: 148-53.
85. Ambrose NS, Johnson M, Burdon DW, Keighlcy MRB. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. Br J Siirg 1984:71:623-5.
86. Deitch EA. Simple intestinal obstruction causes bacterial translocation in man. Arch Surg 1989; 124: 699-701.
87. Sedman PC, Macfie J, Sagar P et al. The prevalence of gut translocation in humans. Gastroenterology 1994; 107: 643-9.
88. Sagar P, MacFie J, Sedman P, May J, Mancey Joncs B, Johnstone D. Intestinal obstruction promotes gut translocation of bacteria. Dis Colon Rectum 1995; 38: 640-4.
89. Rush BF Jr, Sori AJ, Murphy TF, Smith S, Flanagan JJ Jr, Machiedo G\V. Endotoxemia and bacteremia during hemorrhagic shock. Ann Surg 1988; 207: 549-4.
90. Peitzman AB, Udekwu AO, Ochoa J, Smith S. Bacterial translocation in trauma patients. J Trauma 1991; 31: 1083-7.
91. Moore FA, Moore EE, Poggetti R et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 1991; 31: 629-38.
92. Brathwaite CEM, Ross SE, Nagele R, Mure AJ, O'Malley KF, Garcia-Perez FA. Bacterial translocation occurs in humans after traumatic injury: evidence using immunofluorescence. J Trauma 1993; 34: 586-90.
93. Reed LL, Martin M, Manglano R, Newson B, Kocka F, Barrett J. Bacterial translocation following abdominal trauma in humans. Ci_rc Shock 1994; 42: 1-6.
94. Luiten EJT, Hop WCJ, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995; 222: 57-65.
95. Laffineur G, Lescut D, Vincent P, Quandalle P, Wurtz A, Colombel JF. Bacterial translocation in Crohn's disease. Gastroenterol Clin Biol 1992; 16: 777-81.
96. Vincent P, Colombel JF, Lescut D et al. Bacterial translocation in patients with colorectal cancer. J Infect Dis 1988; 158: 1395-6 (Letter).
97. Koha M, Brisbar B, Wikstrom B, Ewrth S, Nord CE. Bacterial colonization and translocation in colorectal carcinoma. Medical Microbiology Letters 1992; 1: 168-76.
98. van Goor H, Rosman C, Grond J, Kooi K, Wubbcls GH, Bleichrodt RP. Translocation of bacteria and endotoxin in organ donors. Arch Surg 1994; 129: 1063-6.
99. Hoch RC, Rodriguez R, Manning T et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21: 839-45.
100. Endo S, Inada K, Yamada Y et al. Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 1994; 22: 949-55.
101. Roumen RM, Frieling JT, van Tits HW, van der Vliet JA, Goris RJ. Endotoxemia after major vascular operations. / Vase Surg 1993; 18: 853-7.
102. Martinez-Pellus AE, Merino P, Bru M et al. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 1993; 21: 1684-91.
103. Shou J, Lappin J, Daly JM. Impairment of pulmonary macrophage function with total parenteral nutrition. Ann Surg 1994; 219: 291-7.
104. Nieuwenhuijzen GAP, Haskel Y, Lu Q et al. Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation. Ann Surg 1993; 218: 791-9.
105. Nolan JP. Endotoxin, reticuloendothelial function, and liver injury. Hcpatology 1981; 1: 458-65.
106. Van Leeuwen PAM, Boermeester MA, Houdijk APJ et al. Clinical significance of translocation. Gut 1994; 35(Suppl 1): S28-34.
107. Xu D, Qi L, Guillory D, Cruz N, Berg RD, Deitch EA. Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J Trauma 1993; 34: 676-83.
108. Deitch EA, Specian RD, Berg RD. Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation, and macrophage products. Crit Care Med 1991; 19: 785-91.
109. Epstein MD, Tchcrvcnkov JI, Alexander JW, Johnson JR, Vester JW. Increased gut permeability following burn trauma. Arch Surg 1991; 126: 198-200.
110. Messick \VJ, Koruda M, Meyer A, Zimmcrman K. Differential changes in intestinal permeability following burn injury. J Trauma 1994; 36: 306-12.
111. Carter EA, Tompkins RG, Schriffin E, Burke JF. Cutaneous thermal injury alters macromolecular permeability of rat small intestine. Surgery 1990; 107: 335-41.
112. Ryan CM, Bailey SH, Carter EA, Schoenfeld DA, Tompkins RG. Additive effects of thermal injury and infection on gut permeability. Arch Surg 1994; 129: 325-8.
113. Salzman AL, Wang H, Wollert PS et al. Endotoxin-induced ileal mucosal hyperpermeability in pigs: role of tissue acidosis. Am J Physio! 1994; 266: G633-46.
114. Hutcheson IR, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxininduced acute intestinal damage in the rat. Br J Pliannacol 1990; 101: 815-20.
115. Kimmings AN, van Deventer SJH, Obertop H, Rauws EAJ, Gouma DJ. Inflammatory and immunologie effects of obstructive jaundice: pathogenesis and treatment. J Am Coll Surg 1995; 181: 567-81.
116. Trancede CM, Andremont AO. Bacterial translocation and Gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 1985; 152: 99-103.
117. Tetteroo GWM, Wagenvoort JHT, Castelein A, Tilanus HW, Ince C, Bruining HA. Selective decontamination to reduce Gram-negative colonisation and infections after oesophageal resection. Lancet 1990; 335:704-7.
118. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. BMJ 1993; 307: 525-32.
119. Blair P, Rowlands BJ, Lowry K, Webb H, Armstrong P, Smilie J. Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit. Surgery 1991; 110: 303-10.
120. Ledingham J, Alcock SR, Eastaway AT, McDonald JC, McKay IC, Ramsay G. Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1988; i: 785-90.
121. Cerra FB, Maddaus MA, Dunn DL et al. Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. Arch Surg 1992; 127: 163-9.
122. Stoutenbeek CP, van Saene HKF. Prevention of pneumonia by selective decontamination of the digestive tract (SDD). Intensive Care Med 1992; 18(Suppl 1): S18-23.
123. Inglis TJJ, Sherratt MJ, Sproat LJ, Gibson JS, Hawkey PM. Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung. Lancet 1993; 341: 911-13.
124. Bion JF, Badger I, Crosby HA et al. Selective decontamination of the digestive tract reduces Gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med 1994; 22: 40-9.
125. Worte! CH, von der Möhlen MAM, van Deventer SJH et al. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in Gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis 1992; 166: 1367-74.
126. Ziegler EJ, Fisher CJ Jr, Sprung CL et al. Treatment of Gram-negative bacteremia and septic shock with a HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA1A Sepsis Study Group. NEnglJMed 1991; 324: 429-36.
127. Greenberg RN, Wilson KM, Kunz AY, Wedel NI, Gorelick KJ. Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, Gramnegative sepsis. Crit Care Med 1992; 20: 730-5.
128. Bone RC, Balk RA, Fein AM et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crii Care Mcd 1995; 23: 994-1006.
129. Greenman RL, Schein RMH, Martin MA et al. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis. The XOMA Sepsis Study Group. JAMA 1991; 266: 1097-102.
130. Warren HS, Danner RL, Munford RS. Anti-cndotoxin monoclonal antibodies. N Engl J Mcd 1992; 326: 1153-7.
131. Wenzel RP. Anti-endotoxin monoclonal antibodies: a second look. N Engl J Mcd 1992; 326: 1151-2 (Editorial).
132. Warren HS, Amato SF, Fitting C et al. Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med 1993; 177: 89-97.
133. Fisher CI Jr, Opal SM, Dhainaut JF et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Cut Care Mcd 1993; 21: 318-27.
134. Fisher CJ Jr, Dhainaut JF, Opal SM et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-Ira Sepsis Syndrome Study Group. JAMA 1994; 271: 1836-43.
135. Olofsson P, Nylander G, Olsson P. Endotoxin transport routes and kinetics in intestinal ischemia. Acta Chintrgica Scandinavica 1985j 151: 635-9.
136. Olofsson P, Nylander G, Olsson P. Endotoxin: routes of transport in experimental peritonitis. Am J Sitrg 1986; 151: 443-6.
137. Olofsson P. Evaluation of the effects of lymph drainage by a thoracic duct fistula in experimental peritonitis. Acta Chintrgica Scandinavica 1988; 154: 453-9.
138. Ziegler TR, Smith RJ, O'Dwyer ST, Demling RH, Wilmore DW. Increased intestinal permeability associated with infection in burn patients. Arch Sitrg 1988; 123: 1313-19.
139. LeVoyer T, Cioffi WO Jr, Pratt L et al. Alterations in intestinal permeability after thermal injury. Arch Surg 1992; 127: 26-30.
140. Deitch EA. Intestinal permeability is increased in burn patients shortly after injury. Surgery 1990; 107: 411-16.
141. Ohri SK, Bjarnason I, Pathi V et al. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg 1993; 55: 1080-6.
142. Pape HC, Dwenger A, Regel G et al. Increased gut permeability after multiple trauma. Br J Sitrg 1994; 81: 850-2.
143. Langkamp-Henken B, Donpvan TB, Pate LM, Maull CD, Kudsk KA. Increased intestinal permeability following blunt and penetrating trauma. Crit Care Med 1995; 23: 660-4.
144. Roumen RMH, Hendriks T, Wevers RA, Goris JA. Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg 1993; 128: 453-7.
145. Sedman PC, MacFie J, Palmer MD, Mitchell CJ, Sagar PM. Preoperative total parenteral nutrition is not associated with mucosal atrophy or bacterial translocation in humans. Br J Surg 1995; 82: 1663-7.
146. Wanidworanum C, Strober W. Predominant role of tumour necrosis factor-x in human monocyte IL-10 synthesis. Jlminunol 1993; 151: 6853-61.
147. Schoenberg MH, Beger HG. Reperfusion injury after intestinal ischemia. Dig Surg 1996; 13: 170-80.
148. Landow L, Andersen LW. Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 1994; 38: 626-39.
149. Boermeester MA, van Leeuwen PAM, Coyle SM, Wolbink GJ, Hack CE, Lowry SF. Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis. Arch Sitrg 1995; 130: 739-48.
150. Michie HR, Manogue KR, Spriggs DR et al. Detection of circulating tumour necrosis. factor after endotoxin administration. N EnglJMcd 1988; 318: 1481-6.
151. van Dcvcnter SJH, Biiller HR, ten Cate JW, Aardcn LA, Hack CE, Sturk A. Experimental endotoxemia in humansanalysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990; 76: 2520-6.
152. Von der Möhlen MAM, Kimmings AN, Wedel NI et al. Inhibition of endotoxin-induccd cytokinc release and neutrophil activation in humans by use of recombinant bactericidal/permeability-incrcasing protein. J Infect Dis 1995; 172: 144-51.